School of Ophthalmology and Optometry, Wenzhou Medical University, Zhejiang, China.
Yiwu Maternal and Child Health Hospital, Jinhua, Zhejiang, China.
Invest Ophthalmol Vis Sci. 2018 Jul 2;59(8):3259-3268. doi: 10.1167/iovs.18-23965.
The purpose of this study was to determine whether either a hyperosmotic or oxidative stress induces NLRP3 inflammasome activation and increases in bioactive IL-1β secretion through transient receptor potential melastatin 2 (TRPM2) activation in primary human corneal epithelial cells (PHCECs).
Real-time PCR, Western blots, and immunofluorescent staining were used to evaluate TRPM2 and NLRP3, ASC, caspase-1, and IL-1β mRNA and protein expression levels, respectively. A CCK-8 assay evaluated cell viability. Hyperosmotic 500 mOsm and oxidative 0.5 mM H2O2 stresses were imposed. TRPM2 expression was inhibited with a TRPM2 inhibitor, 20 μM N-(p-amylcinnamoyl) anthranilic acid (ACA), or TRPM2 siRNA knockdown.
In the hypertonic medium, TRPM2, NLRP3, ASC, caspase-1, and IL-1β gene and protein expression levels rose after 4 hours (P ≤ 0.043), whereas ACA preincubation suppressed these rises (P ≤ 0.044). Similarly, H2O2 upregulated TRPM2 protein expression by 80%, and induced both NLRP3 inflammasome activation and increased bioactive IL-1β secretion (P ≤ 0.036), whereas ACA pretreatment suppressed these effects (P ≤ 0.029). TRPM2 siRNA transfection reduced TRPM2 gene expression by 70% (P = 0.018) in this hyperosmotic medium and inhibited the increases in NLRP3, caspase-1, and IL-1β gene (P ≤ 0.028) and protein expression (P ≤ 0.037).
TRPM2 activation by either a hyperosmotic or oxidative stress contributes to mediating increases in NLRP3 inflammasome activity and bioactive IL-1β expression because inhibiting TRPM2 activation or its expression blunted both of these responses in PHCECs. This association points to the possibility that TRPM2 is a viable target to suppress hyperosmotic-induced corneal epithelial inflammation.
本研究旨在确定在原代人角膜上皮细胞(PHCECs)中,渗透压升高或氧化应激是否通过瞬时受体电位 melastatin 2(TRPM2)的激活诱导 NLRP3 炎性体的激活和生物活性 IL-1β 的分泌增加。
实时 PCR、Western blot 和免疫荧光染色分别用于评估 TRPM2 和 NLRP3、ASC、caspase-1 和 IL-1β 的 mRNA 和蛋白表达水平。CCK-8 测定评估细胞活力。施加高渗 500 mOsm 和氧化 0.5 mM H2O2 应激。用 TRPM2 抑制剂 20 μM N-(对氨肉桂酰)邻氨基苯甲酸(ACA)或 TRPM2 siRNA 敲低抑制 TRPM2 表达。
在高渗培养基中,TRPM2、NLRP3、ASC、caspase-1 和 IL-1β 的基因和蛋白表达水平在 4 小时后升高(P ≤ 0.043),而 ACA 预孵育抑制了这些升高(P ≤ 0.044)。同样,H2O2 使 TRPM2 蛋白表达上调 80%,并诱导 NLRP3 炎性体的激活和增加生物活性的 IL-1β 分泌(P ≤ 0.036),而 ACA 预处理抑制了这些作用(P ≤ 0.029)。在这种高渗培养基中,TRPM2 siRNA 转染使 TRPM2 基因表达降低 70%(P = 0.018),并抑制 NLRP3、caspase-1 和 IL-1β 基因(P ≤ 0.028)和蛋白表达(P ≤ 0.037)的增加。
渗透压升高或氧化应激引起的 TRPM2 激活有助于介导 NLRP3 炎性体活性和生物活性 IL-1β 表达的增加,因为抑制 TRPM2 激活或其表达减弱了 PHCECs 中这两种反应。这种关联表明,TRPM2 是抑制渗透压诱导的角膜上皮炎症的一个可行靶点。